Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €35.15 EUR
Change Today 0.00 / 0.00%
Volume 0.0
SGT On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 10:59 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - seattle genetics inc (SGT)

Name (Connections)Board RelationshipsTitleKey Developments
David Gryska MBA 19 RelationshipsDirector and Chairman of Audit Committee 
John McLaughlin J.D. 24 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 
John Orwin 140 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - seattle genetics inc (SGT)

Name (Connections)Board RelationshipsTitle
Felix Baker Ph.D. 40 RelationshipsLead Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
John McLaughlin J.D. 24 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
SGT Compensation vs. Industry
759.3K
354.8K
Chief Executive Officer
422.1K
263.8K
Chief Financial Officer
472.3K
345.7K
Chief Operating Officer
Share price activity for SEATTLE GENETICS INC (SGT)
52 Week Price Performance
SGT
Industry Average

Nominating Committee* - seattle genetics inc (SGT)

Name (Connections)Board RelationshipsTitleKey Developments
Felix Baker Ph.D. 40 RelationshipsLead Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeSeattle Genetics, Inc. Announces the Resignation of Srinivas Akkaraju from the Board as Class I Director
06/22/15
Nancy Simonian M.D. 26 RelationshipsDirector and Chairman of Nominating & Corporate Governance CommitteeSeattle Genetics Inc. Announces Executive Changes
11/18/14
Marc Lippman M.D. 9 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeSeattle Genetics Inc. Announces Resignation of Franklin M. Berger as Board of Directors
03/28/14

Corporate Governance Committee* - seattle genetics inc (SGT)

Name (Connections)Board RelationshipsTitle
Felix Baker Ph.D. 40 RelationshipsLead Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Marc Lippman M.D. 9 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Nancy Simonian M.D. 26 Relationships--
SGT and Competitor
Insiders vs. External
Board
11%
89%
Seattle Genetics, Inc.
10%
90%
Ariad Pharmaceuticals Inc.
0%
100%
Morphosys AG
0%
100%
Genmab A/S
50%
50%
Pfizer Limited
29%
71%
INSYS Therapeutics, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGT:GR €35.15 EUR 0.00

SGT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ARIAD Pharmaceuticals Inc $7.28 USD -1.81
Genmab A/S kr603.00 DKK +26.00
Insys Therapeutics Inc $33.53 USD +0.94
MorphoSys AG €62.11 EUR +1.58
Pfizer Ltd/India 2,312 INR -35.60
View Industry Companies
 

Industry Analysis

SGT

Industry Average

Valuation SGT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.3x
Price/Book 28.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEATTLE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.